TEVA
Teva Pharmaceutical Industries Ltd
$17.08
Earnings Summary
Revenue | $4332Mn |
Net Profits | $-437Mn |
Net Profit Margins | -10.09% |
Highlights
Teva Pharmaceutical Industries Ltd’s revenue jumped 12.52% since last year same period to $4332Mn in the Q3 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 4.08% jump in its revenue since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit fell -646.25% since last year same period to $-437Mn in the Q3 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 48.28% jump in its net profits since last 3-months.
Teva Pharmaceutical Industries Ltd’s net profit margin fell -585.47% since last year same period to -10.09% in the Q3 2024. On a quarterly growth basis, Teva Pharmaceutical Industries Ltd has generated 50.31% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Teva Pharmaceutical Industries Ltd post its latest quarter earnings
EPS Estimate Current Quarter | 0.65 |
EPS Estimate Current Year | 0.65 |
Highlights
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current quarter stand at 0.65 - a 18.18% jump from last quarter’s estimates.
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) estimates for the current year stand at 0.65.
Key Ratios
Key ratios of the Teva Pharmaceutical Industries Ltd post its Q3 2024 earnings
Earning Per Share (EPS) | 0.69 |
Highlights
Teva Pharmaceutical Industries Ltd’s earning per share (EPS) jumped 15% since last year same period to 0.69 in the Q3 2024. This indicates that the Teva Pharmaceutical Industries Ltd has generated 15% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-07-31 | 0.55 | 0.61 | 10.91% |
2024-11-06 | 0.65 | 0.69 | 6.15% |
2024-05-08 | 0.51 | 0.48 | -5.88% |
₹0 US Stocks a/c Opening Fee